Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial
Takashima, Tsutomu, MD, Mukai, Hirofumi, Dr, Hara, Fumikata, MD, Matsubara, Nobuaki, MD, Saito, Tsuyoshi, MD, Takano, Toshimi, MD, Park, Youngjin, Prof, Toyama, Tatsuya, Prof, Hozumi, Yasuo, MD, Tsurutani, Junji, MD, Imoto, Shigeru, Prof, Watanabe, Takanori, MD, Sagara, Yoshiaki, MD, Nishimura, Reiki, MD, Shimozuma, Kojiro, Prof, Ohashi, Yasuo, Prof
Published in The lancet oncology (2016)
Published in The lancet oncology (2016)
Get full text
Journal Article